Skip to main content
Dayna Isaacs, MD, Internal Medicine, Los Angeles, CA

DaynaIsaacsMDMPH(She/Her)

Internal Medicine Los Angeles, CA

Resident Physician

Dr. Isaacs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Isaacs' full profile

Already have an account?

Summary

  • PGY-3 internal medicine resident physician at UCLA. Expertise in health policy, public health, advocacy, and street medicine. Committed to partnering with underserved and marginalized populations. Interested in clinical research to enhance oncologic treatment access and combat social determinants of health. Applying for a fellowship in hematology/oncology.
  • LinkedIn

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2021 - 2024
  • University of California, Davis, School of Medicine
    University of California, Davis, School of MedicineClass of 2021
  • UC Davis School of Medicine
    UC Davis School of MedicineMPH, Epidemiology , “Excellence in Public Health” Award, 2016 - 2017

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2021 - 2025

Publications & Presentations

PubMed

Journal Articles

  • Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy  
    Dayna Jill Isaacs, Nikhita Kathuria-Prakash, Robin Hilder, Melissa G. Lechner, Alexandra Drakaki, Current Cancer Reports, 1/29/2024
  • Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with pre-existing type 1 diabetes mellitus  
    • Hilder R, Tsai K, Quandt Z, Isaacs DJ, Drakaki D, Xing Y, In GK, Angell TE, Lechner MG, Frontiers in Endocrinology, 10/11/2023

Abstracts/Posters

  • Are severe immune-related adverse events more likely in patients with preexisting autoimmune disease?
    Isaacs DJ, Hilder R, Drakaki D, Lechner MG, Journal of Clinical Oncology, 2023

Authored Content

  • We Should Disaffiliate from the AOA Honor Medical SocietyFebruary 2024

Press Mentions

  • What I wish I knew in residency about collective bargaining
    What I wish I knew in residency about collective bargainingMarch 21st, 2024
  • ASCO Hosts Cancer Care Caucus; Three ASCO-Led Resolutions Become AMA Policy
    ASCO Hosts Cancer Care Caucus; Three ASCO-Led Resolutions Become AMA PolicyFebruary 2nd, 2024
  • Why Are Physicians Unionizing?
    Why Are Physicians Unionizing?September 21st, 2022

Professional Memberships